Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,641 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05009537Recruiting
Optical genome testing for blood cancer diagnosis
This study tests a special way of looking at chromosomes to help diagnose blood-related cancers or blood disorders. If you’re having samples taken for chromosome testing, this trial may use your sample to see if the method helps with diagnosis.
BrestAges Any age - NCT06752057Recruiting
Personalized vaccine plus immunotherapy and radiation for advanced lung cancer
This study tests a combination of a personalized vaccine made from your tumor's unique markers, a type of immunotherapy (PD-1 inhibitor), and radiation. The goal is to see if this mix can work better for advanced lung cancer that has progressed after initial treatment.
Nanchang, JiangxiAges 18–70 - NCT07341932Recruiting
Heart mapping test for stable coronary artery disease treatment
This trial tests whether a non-invasive heart mapping technique can guide treatment for stable coronary artery disease, potentially avoiding more expensive or invasive tests. You may join if you have stable angina and a blockage of 50-90% in a major heart artery.
Beijing, Beijing MunicipalityAges 18–80 - NCT05008744Recruiting
Laser treatment for twin-to-twin transfusion using one shared placenta
This study tests a laser procedure that seals abnormal blood vessel connections in identical twins sharing one placenta (twin-to-twin transfusion syndrome). The goal is to improve outcomes by stopping unbalanced blood flow between the twins.
Seattle, WashingtonAges Any age - NCT07242417RecruitingEarly Phase 1
TC-G203 for adults with GPC3-positive advanced solid tumors
This trial tests an experimental cell therapy (TC-G203) for people with advanced solid tumors that have a specific protein called GPC3. It aims to see if this treatment is safe and effective for those who haven't responded to standard treatments.
Beijing, Beijing MunicipalityAges 18–75 - NCT07242456RecruitingPhase 2/Phase 3
Comparing two treatments for H. pylori infection
This study tests two different combinations of medications to treat H. pylori, a stomach bacteria that can cause ulcers. You would take one of the two combinations for a short time to see which works better at getting rid of the infection.
Hangzhou, ZhejiangAges 18–70 - NCT07660276Enrolling by invitation
AI predicts prostate cancer spread from biopsy
This study uses an artificial intelligence (AI) system to look at prostate biopsy samples and predict if the cancer has spread to the lymph nodes. It may help doctors decide on the best treatment without needing extra surgery or scans.
Changsha, HunanAges 18–90 - NCT07239375Recruiting
Bone Marrow Infusion for Blood Cancer Patients in Critical Care
This trial studies a way to give fluids and medicines directly into the bone marrow (intraosseous infusion) for people with serious blood diseases who are in critical condition. It may help when regular IV access is difficult or urgent.
Taiyuan, ShanxiAges 18–65 - NCT06918275Enrolling by invitation
Keyhole surgery for C-section scar defect repair
This study tests a keyhole surgery (laparoscopy) to repair a C-section scar defect (isthmocele). It is for women who have symptoms from the defect and want to preserve their ability to get pregnant in the future.
Istanbul, IstanbulAges 18–45 - NCT06829706Recruiting
Modified smell training for smell loss after a virus
This study tests a new way of doing smell training to help people whose sense of smell has not recovered after a viral illness. It may help you smell things better again.
BeijingAges 18–80 - NCT06789198RecruitingPhase 1
Peptide Vaccine for Fibrolamellar Cancer and Related Tumors
This trial tests a vaccine designed to target cancer cells with a specific genetic change (DNAJB1-PRKACA). It is for people whose fibrolamellar liver cancer or other tumors with this change are in complete remission after prior treatment, to help prevent the cancer from coming back.
TübingenAges 12 years+ - NCT07240194RecruitingPhase 2
A study of a new drug combo for large B-cell lymphoma with TP53 changes
This trial tests a combination of three drugs (glofitamab, a PD-1 antibody, and lenalidomide) for people with relapsed or refractory large B-cell lymphoma that has a TP53 change. The goal is to see if this combination works better for patients who cannot have a stem cell transplant.
Nanjing, JiangsuAges 18 years+ - NCT06581939Recruiting
Early rehab with nutrition after ICU ventilation
This study tests whether starting physical therapy and tailored nutrition early and continuing for a longer time helps people recover after being on a breathing machine and blood pressure support in the ICU.
AlbiAges 18 years+ - NCT07239297Enrolling by invitation
Pathology study using existing patient data
This trial reviews stored tissue slides and medical records to build better computer models for diagnosing diseases. No new treatments are tested.
Guangzhou, GuangdongAges 18–75 - NCT07239115RecruitingPhase 3
Levetiracetam to prevent seizures after brain tumor surgery
This trial tests whether the drug levetiracetam can prevent seizures in people who have brain tumor surgery. If you are having surgery to remove a brain tumor and have never had a seizure, this study may help keep you from having one after the operation.
BeijingAges 18–75 - NCT07349095Recruiting
AI-assisted color test for gum redness around dental implants
This trial uses an AI tool to check for redness (erythema) in the gum tissue around dental implants. It aims to make diagnosis faster and more accurate during regular check-ups.
ShanghaiAges 18 years+ - NCT07382063Enrolling by invitation
Nerve block effects on diaphragm in kids having arm surgery
This study tests a special numbing shot (nerve block) around the shoulder to see how it affects the muscle that helps kids breathe (the diaphragm) during and after arm surgery. It may help doctors choose safer pain methods for school-aged children.
ShanghaiAges 6–12 - NCT07237373Recruiting
Heat ablation for benign thyroid nodules
This trial tests a minimally invasive procedure called thermal ablation (using heat) to shrink benign thyroid nodules that cause symptoms like pressure or cosmetic issues, or overactive (hot) nodules. It offers an alternative to surgery or radioactive iodine.
BrugesAges 18 years+ - NCT07235865Recruiting
Blood test to find and monitor heart masses
This trial uses a blood test (liquid biopsy) to help find and monitor heart masses without surgery. It may help diagnose what the mass is and how it changes over time.
Milan, ItaliaAges 12 years+ - NCT07234617Recruiting
Green Prescription Program Study for Pregnant Women
This study looks at the Green Prescription program, which is a special health program for pregnant women. The goal is to see how well it works for women who are less than 32 weeks pregnant and speak French.
StrasbourgAges 18 years+ - NCT05529940RecruitingPhase 3
FOLFIRINOX around surgery for resectable pancreatic cancer
This trial compares giving chemotherapy with FOLFIRINOX before and after surgery versus giving it mainly after surgery for people with resectable pancreatic duct cancer. It aims to improve outcomes by timing the treatment around the operation.
SeoulAges 19–80 - NCT04972669Recruiting
Electrical acupuncture to treat leaks after prostate surgery
This trial studies whether electrical acupuncture can reduce urine leakage (incontinence) after prostatectomy. It is meant for people a few weeks to months after surgery whose cancer markers and symptoms suggest they may be good candidates.
Nanjing, JiangsuAges Up to 75 years - NCT07234331Recruiting
Studying antibiotic resistance in nursing home residents
This trial looks at antibiotic resistance by testing wastewater in nursing homes. It aims to understand how resistance spreads and how to better protect residents.
AngersAges 18 years+ - NCT07232095RecruitingPhase 4
7-Day treatment for H. pylori with new acid blocker and antibiotics
This trial tests a 7-day combination of vonoprazan, high-dose amoxicillin, and bismuth to treat Helicobacter pylori infection in people who have never been treated for it before. The goal is to see if this short course is effective and safe for curing the infection.
Nanjing, JiangsuAges 18–70
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,641 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.